"McLaren Macomb is a 288-bed tertiary teaching facility located in Mount Clemens, Michigan. McLaren Macomb provides a full range of services, including cardiovascular care at the Mat Gaberty Heart Center, award winning cancer services at the Ted B. Wahby Cancer Center, comprehensive orthopedic services and a state-of-the-art elective Surgery Center. The hospital is verified as a Level II Trauma Center and operates one of the busiest Emergency Centers in the area."

During the past decade, McLaren Macomb conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 19 clinical trials were completed, i.e. on average, 316.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McLaren Macomb" #1 sponsor was "SWOG Cancer Research Network" with 13 trials, followed by "NSABP Foundation Inc" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Michigan State University" with 2 trials sponsored and "Yale University" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Macomb" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "Novartis" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "McLaren Macomb" are "Breast Cancer" (11 trials), "Prostate Cancer" (5 trials), "Lung Cancer" (4 trials), "Atrial Fibrillation" (3 trials) and "Coronary Artery Disease" (3 trials). Many other conditions were trialed in "McLaren Macomb" in a lesser frequency.

Most popular intervention types in "McLaren Macomb" are "Drug" (21 trials), "Other" (12 trials), "Biological" (4 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Placebo" (3 trials), "bevacizumab" (3 trials) and "biologic sample preservation procedure" (3 trials). Other intervention names were less common.

The vast majority of trials in "McLaren Macomb" are 24 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "McLaren Macomb". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in McLaren Macomb, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in McLaren Macomb, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".

McLaren Macomb has several departments that took part in Clinical trials: "Michigan Vascular Center/McLaren- Flint" - 2 trials, "McLaren Bay Heart and Vascular" - 2 trials